Dissolution and pharmacokinetics of baicalin-polyvinylpyrrolidone coprecipitate

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 11, 2013, Pages 1670-1678

  Li, Bibo ^b   He, Mei ^c   Li, Wei ^a   Luo, Zhibin ^b   Guo, Ying ^a   Li, Yajun ^a   Zang, Chunbao ^a   Wang, Bo ^a   Li, Fang ^a   Li, Shaolin ^a   Ji, Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Third People's Hospital of Chongqing   (China)

^c Chongqing Cancer Institute   (China)

Author keywords

baicalin; dissolution; in vitro in vivo relationship; pharmacokinetics; solid dispersion

Indexed keywords

BAICALIN; POVIDONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BEAGLE DOG; CALIBRATION; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG SOLUBILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; QUALITY CONTROL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

BAICALIN; DISSOLUTION; IN-VITRO IN-VIVO RELATIONSHIP; PHARMACOKINETICS; SOLID DISPERSION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DOGS; FLAVONOIDS; PLANT EXTRACTS; POVIDONE; SCUTELLARIA; SOLUBILITY;

EID: 84886085817     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12146     Document Type: Article

References (19)

1. Shieh DE, et al. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 2000; 20: 2861-2865.
2. Jang SI, et al. Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 2003; 25: 585-594.
3. Wan JY, et al. Protective effect of baicalin against lipopolysaccharide/ d-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur J Pharmacol 2008; 587: 302-308.
4. Park SW, et al. Protective effect of baicalin against carbon tetrachloride-induced acute hepatic injury in mice. J Pharm Sci 2008; 106: 136-143.
5. Srinivas NR,. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica 2010; 40: 357-367.
6. Li C, et al. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos 2011; 32: 427-445.
7. Li BB, et al. Preparation and characterization of baicalin-poly- vinylpyrrolidone coprecipitate. Int J Pharm 2011; 408: 91-96.
8. Xing J, et al. Absorption and enterohepatic circulation of baicalin in rats. Life Sci 2005; 78: 140-146.
9. Liu CZ, et al. Design and evaluation of San-huang dispersible tablet-an efficient delivery system for traditional Chinese medicine. Pharm Dev Technol 2009; 14: 506-515.
10. Wu JM, et al. Study on the bioavailability of baicalin-phospholipid complex by using HPLC. Biomed Chromatogr 1999; 13: 493-495.
11. Liu X, et al. LC determination and pharmacokinetic study of hyperoside in rat plasma after intravenous administration. Yakugaku Zasshi 2010; 130: 873-879.
12. Wang Y, et al. Simultaneous determination of puerarin, daidzein, baicalin, wogonoside and liquiritin of GegenQinlian decoction in rat plasma by ultra-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 1820-1826.
13. Liu TM, Jiang XH,. Studies on the absorption kinetics of baicalin and baicalein in rats' stomachs and intestines. Zhongguo Zhong Yao Za Zhi 2006; 31: 999-1001.
14. Zhang H, et al. Absorption of flavones in Gegenqinlian decoction and different compatibilities in rat everted gut scas. Zhongguo Zhong Yao Za Zhi 2011; 36: 3332-3337.
15. Akao T, et al. Baicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000; 52: 1563-1568.
16. Liu J, et al. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-β-cyclodextrin. Int J Pharm 2006; 312: 137-143.
17. Bikiaris DN,. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 2011; 8: 1501-1519.
18. Janssens S, Van den Mooter G,. Review: physical chemistry of solid dispersions. J Pharm Pharmacol 2009; 61: 1571-1586.
19. Ivanisevic I,. Physical stability studies of miscible amorphous solid dispersions. J Pharm Sci 2010; 99: 4005-4012.